← Back
$BCAX All transactions

Bicara Therapeutics Inc.

▲ BUY
9 / 10

Conviction

$ Value

$35.2M

Shares

2,200,000

Price

$16

Filed

Mar 2

Why this score? (9/10)
  • Open market buy (+3)
  • Trade value >= $5.0M (+3)
  • Director (+1)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

RA CAPITAL MANAGEMENT, L.P.

Title

CIK

0001346824

Roles

Director 10% Owner

Transaction Details

Transaction Date

2026-02-26

Code

P

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

2,200,000

Footnotes

RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein. | Held directly by the Fund. | Held directly by Nexus Fund III. | The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

Filing Info

Accession No.

0001231919-26-000231

Form Type

4

Issuer CIK

0002023658

RA CAPITAL MANAGEMENT, L.P.'s History

Date Ticker Type Value
2026-04-22 ACRV A $7.0M
2026-04-20 VOR $2.7M
2026-04-17 VOR $7.5M
2026-04-15 VOR $859K
2026-04-14 VOR $2.5M
2026-04-13 VOR $8.6M
2026-04-10 VOR $13K
2026-04-09 VOR $2.2M
2026-04-08 VOR $5.8M
2026-04-08 VOR $2.2M

Other Insiders at BCAX (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $4.8M 2026-02-26
Meisner Lara
Chief Legal Officer
2026-02-02
Cohlhepp Ryan
President and COO
$984K 2026-04-15
Hyep Ivan
Chief Financial Officer
$717K 2026-04-21
Mazumdar Claire
Chief Executive Officer
$1.5M 2026-04-20
Raben David
Chief Medical Officer
$410K 2026-03-25